[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334750-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334750-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exosomes-in-the-pathogenesis-and-treatment-of-cancer-related-cachexia-review","Exosomes in the pathogenesis and treatment of cancer-related cachexia - review","","Cancer-related cachexia is a metabolic syndrome defined by progressive weight loss, adipose tissue breakdown, and skeletal muscle atrophy. It is a common and severe complication of advanced cancers, strongly worsening patients’ quality of life and survival. The molecular mediators remain unclear, and the cellular pathways driving muscle atrophy and lipidolysis require further study. This review summarizes how exosomes, small extracellular vesicles involved in intercellular communication, contribute to cancer-induced cachexia and highlights their diagnostic and therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exosomes-in-the-pathogenesis-and-treatment-of-cancer-related-cachexia-review/334750/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exosomes-in-the-pathogenesis-and-treatment-of-cancer-related-cachexia-review/334750.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is cancer-related cachexia and what major features does it include?","Question",{"text":63,"@type":64},"Cancer-related cachexia is a metabolic syndrome marked by weight loss, adipose tissue decomposition, and progressive skeletal muscle atrophy. It is often accompanied by lipidolysis and systemic inflammation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do exosomes relate to the development of cancer-related cachexia?",{"text":68,"@type":64},"Exosomes are small extracellular vesicles that facilitate intercellular communication. Studies indicate they contribute to cachexia onset and progression by transporting active molecules such as nucleic acids and proteins.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are exosomes considered important for diagnosis or treatment?",{"text":72,"@type":64},"The review states exosomes have potential as diagnostic markers and therapeutic strategies for cachexia. Their involvement in cancer-induced muscle and adipose degradation suggests new approaches for diagnosis and treatment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334750,1790832598,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ru etal. Journal of Translational Medicine (2024) 22:408  \n[https://doi.org/10.1186/s12967-024-05201-y](https://doi.org/10.1186/s12967-024-05201-y)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nExosomes in the pathogenesis and treatment of cancer-related cachexia  \nQin Ru 1, Lin Chen 1, Guodong Xu 1 andYuxiang Wu 1*  \nAbstract  \nCancer-related cachexia is a metabolic syndrome characterized by weight loss, adipose tissue decomposition, and progressive skeletal muscle atrophy. It is a major complication of many advanced cancers and seriously affects the quality of life and survival of cancer patients. However, the specific molecules that mediate cancer-related cachexia remain elusive, and the fundamental cellular and molecular mechanisms associated with muscle atrophy and lipidolysis in cancer patients still need to be investigated. Exosomes, a newly discovered class of small extracellular vesicles that facilitate intercellular communication, have a significant role in the onset and development of various cancers. Studies have shown that exosomes play a role in the onset and progression of cancer-related cachexia by transporting active molecules such as nucleic acids and proteins. This review aimed to provide an overview of exosome developments in cancer-induced skeletal muscle atrophy and adipose tissue degradation. More importantly, exosomes were shown to have potential as diagnostic markers or therapeutic strategies for cachexia and were prospected, providing novel strategies for the diagnosis and treatment of cancer-related cachexia. Keywords Cancer-related cachexia, Exosomes, Non-coding RNAs, Muscle atrophy, Lipidolysis  \nIntroduction  \nCachexia is a complex metabolic syndrome characterized by weight loss, dyshomeostasis of energy metabolism, and systemic inflammation [1, 2]. Etymologically, the word cachexia is derived from the two Greek words“Kakos” and “hexis” meaning “bad condition” [3]. Cachexia is often associated with malignant and multiple chronic non-malignant diseases such as cancer, chronic obstructive pulmonary disease, chronic heart failure, rheumatoid arthritis, kidney disease, acquired immune deficiency syndrome, and septicemia [2, 4]. It is important to mention that nutritional support therapy is not effective in reversing the progression of cachexia [5].  \n*Correspondence:  \nYuxiang Wu  \n[yxwu@jhun.edu.cn](yxwu@jhun.edu.cn)  \n1Institute of Intelligent Sport and Proactive Health， Department of Health and Physical Education, Jianghan University, Wuhan 430056, China  \nCachexia gradually leads to physiological dysfunction, promoting the development of multiple organ dysfunction syndromes. Therefore, preventing cachexia holds significant clinical importance in improving the disease progression and the quality of life of patients.  \nCancer-related cachexia occurs in the advanced stages of many malignant tumors and is characterized by persistent wasting of adipose and skeletal muscle [6, 7]. Cancer-related cachexia is always accompanied by lipidolysis, skeletal muscle atrophy, and systemic inflammation, resulting in progressive dysfunction and reduced quality of life. Cancer-related cachexia is a prominent contributor to mortality among cancer patients, with previous research indicating that over 20% of cancer patients’ deaths may be indirectly caused by cachexia resulting from cancer or cancer treatment [3]. Many factors influence the occurrence of cancer-related cachexia. They can be attributed to a variable combination of reduced food intake, multiple abnormalities in  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this artic","cbCaiaRQBG7Z7Hy5","https://ap.wps.com/l/cbCaiaRQBG7Z7Hy5","pdf",3445957,"English","# Abstract\n# Introduction\n## Definition and clinical importance of cachexia\n## Cancer-related cachexia features and burden\n## Contributing factors and diagnostic considerations","[{\"question\":\"What is cancer-related cachexia and what major features does it include?\",\"answer\":\"Cancer-related cachexia is a metabolic syndrome marked by weight loss, adipose tissue decomposition, and progressive skeletal muscle atrophy. It is often accompanied by lipidolysis and systemic inflammation.\"},{\"question\":\"How do exosomes relate to the development of cancer-related cachexia?\",\"answer\":\"Exosomes are small extracellular vesicles that facilitate intercellular communication. Studies indicate they contribute to cachexia onset and progression by transporting active molecules such as nucleic acids and proteins.\"},{\"question\":\"Why are exosomes considered important for diagnosis or treatment?\",\"answer\":\"The review states exosomes have potential as diagnostic markers and therapeutic strategies for cachexia. Their involvement in cancer-induced muscle and adipose degradation suggests new approaches for diagnosis and treatment.\"}]","Exosomes in the pathogenesis and treatment of cancer-related cachexia - review | PDF",1790008171,48]